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The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is a patient-reported outcome
measure (PROM) that is widely used to evaluate the pain, stiffness, and physical function of patients with osteoar-
thritis of the hip and knee. Although the WOMAC has also been used for patients after foot and ankle surgery,
it has not been validated for this purpose. A total of 130 patients with surgically treated ankle fractures completed
the WOMAC, Visual Analogue Scale Foot and Ankle (VAS FA), Lower Extremity Functional Scale (LEFS), 15D
Health-Related Quality-of-Life Questionnaire (15D), and Visual Analog Scale for General Health (VAS general
health) after foot and ankle surgery. The structural validity of the WOMAC was assessed by using Cronbach’s a,
and convergent validity was tested between the WOMAC and reference outcome measures. Cronbach’s a for the
index score was 0.98 and 0.95, 0.86, and 0.98 for the Pain, Stiffness, and Physical Function subscales, respectively.
The Spearman correlation coefﬁcients were ‒0.84, ‒0.74, ‒0.58, and 0.55 for the VAS-FA, LEFS, 15D, and VAS gen-
eral health, respectively. The relationships with the VAS-FA, LEFS, 15D, and VAS general health were strong. All
relationships were statistically signiﬁcant (p < .001). The WOMAC provides valid scores for assessing pain, stiff-
ness, and physical function in patients having undergone ankle fracture surgery.
© 2019 by the American College of Foot and Ankle Surgeons. All rights reserved.Level of Clinical Evidence: 3
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College of Foot and Ankle Surgeons. All rights reserved.Patient-reported outcome measures (PROMs) are useful tools in
evaluating outcomes after surgical interventions (1). The use of PROMs
in clinical practice and scientiﬁc studies has gained increased interest in
recent years, because these measures provide a means to evaluate out-
comes from the patients’ perspective (2,3). The beneﬁts of using PROMs
are evaluation of the patients’ functional status, the differences between
patients, the effectiveness of treatment, and the ability to perform
benchmarking (4).
There is a broad variety of PROMs used among foot and ankle
patients, with notable differences in the validity and reliability of these
tools (1). There is no consensus on which PROMs to use for any individ-
ual procedures in the treatment of foot and ankle pathologies (5,6). The
US Food and Drug Administration created guidelines for the proper
development and validation of PROMs that are intended for medicaluse (4,7,8). The US Food and Drug Administration guidelines emphasize
that PROMs should always be reviewed for reliability, validity, ability to
detect change, and interpretability before application in clinical or
research use (4). The measurement properties should be assessed for
the current study population and study design (4). These guidelines are
important to make the ﬁeld of outcome measures consistent and clear
(9,10).
The Western Ontario and McMaster Universities Osteoarthritis
Index (WOMAC) is a PROM that is generally used for evaluating physical
disability and symptoms in patients with osteoarthritis of the hip and
knee (11,12). There are 2 versions of the WOMAC scale. One version
uses a Likert scale (scores from 1 to 5, categorical) and the other uses a
Visual Analog Scale (VAS) (scores from 0 to 100, continuous) (13). The
VAS scaled version has been found to be valid, reliable, responsive, and
disease speciﬁc for hip and knee osteoarthritis, rheumatoid arthritis,
and ﬁbromyalgia (11,12,14,15).
The validity and reliability of the WOMAC questionnaire have not
been tested for the assessment of outcomes after ankle surgery. The
aim of this study was to validate the VAS version of the WOMAC ques-
tionnaire for patients having undergone ankle fracture surgery.
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Patients were identiﬁed from a database into which patients had been previously pro-
spectively entered or searched from hospital electronic databases by using National Institute
for Health and Welfare procedure codes (NHJ10 [ankle fracture osteosynthesis]; NHU20
[removal of implants from foot or ankle]). The inclusion criteria were full understanding of
written Finnish, age ≥18 years, and previous foot and ankle surgery. The exclusion criteria
were isolated foot fractures and surgery as a result of infection, tumor, or osteoarthritis.
The patients were approached in a cross-sectional manner via mail. Patients who agreed
to participate completed the WOMAC, the Lower Extremity Functional Scale (LEFS), the
Visual Analogue Scale Foot and Ankle (VAS-FA), and the 15D generic Health-Related Quality
of Life (HRQoL) (15D) instruments. In addition, patients completed questions about general
health state, physical activity [Kasari FIT index (16)], and a VAS of general health. The study
protocol was approved by the regional ethics committee of the hospital district.
Instruments
WOMAC
The WOMAC (version 3.0) is a VAS scaled 24-item instrument con-
sisting of 3 subscales: Pain, Stiffness, and Physical Function (11,12,17).
The Pain subscale consists of 5 items, the Stiffness subscale consists of 2
items, and the Physical Function subscale consists of 17 items (17).
Higher scores in the WOMAC scale and in its subscales indicate greater
degree of physical disability and more symptoms, whereas lower scores
indicate better physical performance and fewer symptoms (17). Each
subscale has been found to ﬁt well in the Rasch model, and the Pain and
Physical Function subscales have shown unidimensional construct in
factor analyses (17). Cronbach’s a (internal consistency) values were
.82, .80, and .95 for the Pain, Stiffness, and Physical Function subscales,
respectively (17). The WOMAC has been translated, and both versions
have been validated in the Finnish language (18,19). The modiﬁed
instructions of the questionnaire asked for the patient’s view about his
or her foot, ankle, or both in completing the survey.
VAS-FA
The VAS-FA is a foot and ankle‒speciﬁc PROM that has been validated
for foot and ankle patients to assess function, pain, and other complaints
(20−22). The scale contains 20 items on a VAS (0−100 mm, worst to best)
and yields a score between 0 and 100 (23). The items are divided into 3
modules as follows: Pain (4 items), Function (11 items), and Other Com-
plaints (5 items) (23). Cronbach’s a values for the subscales of the ques-
tionnaire have been evaluated to be .94 for Function, .91 for Pain, and .81
for Other Complaints, thus indicating high internal consistency (22). The
VAS-FA has very high intraclass correlation coefﬁcients for total score
(0.97) and its different subscales (0.95−0.97), indicating high relative reli-
ability (22). The VAS-FA has been validated in the Finnish language (22).
LEFS
The LEFS is a patient-reported outcome instrument assessing the
function of patients after foot and ankle surgery (24,25). It consists of
20 items with 5 response categories. The LEFS is scored from 0 to 4
points, with higher scores indicating better function and lower scores
indicating worse function (25). The LEFS instrument has been shown to
be reliable and to have high construct validity and sensitivity to detect
change in assessing the foot and ankle function (25). Cronbach’s a value
for the LEFS is .96, indicating high internal consistency (25). The Finnish
version of the LEFS has comparable validity and reliability with the orig-
inal version of the LEFS (26).
15D
The 15D is a generic, self-administered HRQoL instrument consisting
of 15 subscales measuring distinct dimensions related to HRQoL (27):Moving, Seeing, Hearing, Breathing, Sleeping, Eating, Speech, Excretion,
Usual Activities, Mental Function, Discomfort and Symptoms, Depres-
sion, Distress, Vitality, and Sexual Activity. All items have 5 response
categories from 1 (representing the best state) to 5 (representing the
worst state) for each dimension. The 15D index is calculated from all
subscale scores. The index score varies from 0 to 1, representing the
worst to the best imaginable state of HRQoL. The 15D has been com-
pared with other generic HRQoL instruments in previous international
studies, in which the 15D has been shown to yield comparable results
to the reference measures (27−30).
Statistical Methods
Clinical and sociodemographic data are presented as mean §
standard deviation (SD) values, medians with interquartile ranges
(IQRs), 95% conﬁdence intervals (CIs), or counts with percentages.
Distribution of the WOMAC score was assessed. Scale targeting and
coverage were investigated by calculating the percentage of mini-
mum and maximum points. A ﬂoor or ceiling effect was considered
to be conﬁrmed when 15% of patients scored the minimum or max-
imum points (30). The authors hypothesized that the WOMAC
would not reach the ﬂoor or ceiling values. Cronbach’s a (internal
consistency) was used to evaluate the structural validity of the
WOMAC instrument (31). The authors hypothesized that the inter-
nal consistency would be not less than .70 (32).
The Spearman correlation coefﬁcients of the WOMAC and refer-
ence instruments were calculated to assess convergent validity of
the WOMAC instrument. The correlations were represented accord-
ing to the rule of thumb for Interpreting the size of a correlation
coefﬁcient (33), namely as negligible (0.00‒0.29), low (0.30‒0.49),
moderate (0.50‒0.69), high (0.70‒0.89), and very high (0.90‒1.00)
correlation. Linearity between the WOMAC and reference outcomes
(the LEFS, the VAS-FA, and the 15D mean score) was assessed. Fur-
ther, linear regression analyses were used to identify the appropri-
ate predictors of the WOMAC standardized by age, postoperative
body mass index (BMI), and sex. The regression coefﬁcient b value
indicates how strongly each predictor variable inﬂuences the crite-
rion variable (the mean LEFS, VAS-FA, and 15D scores). The b value
was measured in units of SD. Cohen reference values of 0.1, 0.3,
and 0.5 refer to small, moderate, and strong correlations, respec-
tively. The authors hypothesized that there would be a strong cor-
relation between the WOMAC and the reference instruments.
Patients with complete data were added to the analyses. Analyses
were performed by using R (version 1.1.453) statistics software. Results
are reported according to the Strengthening the Reporting of Observa-
tional Studies in Epidemiology (STROBE) statement (34) and the COn-
sensus-based Standards for the selection of health status Measurement
Instruments (COSMIN) (35).
Results
Of the total of 212 recruited patients, 130 (61%) met the inclu-
sion criteria and were included in the analysis (Table 1). The mean
follow-up time was 4 years (range 1 month to 14 years) after the
last operation. Of the 130 included patients, 49 (38%) patients had
lateral malleolus fracture, 37 (28%) had trimalleolar fracture, 31
(24%) had medial malleolus fracture, and 13 (10%) had other frac-
tures. Fractures were either closed (n = 119) or open (n = 11). Sur-
gery was performed with plates and screws (n = 116 [89%]), screws
(n = 5 [4%]), soft tissue ﬂap (n = 5 [4%]), external ﬁxation (n = 1 [1%]),
tibial nail (n = 1 [1%]), or multiple techniques (n = 2 [2%]).
The median (range) of the WOMAC index score was 8.0 (0 to
85.9) points (Figs. 1 and 2). Minimum points were observed for 4
patients. No patients scored maximum points. Floor or ceiling
Fig. 1. Distribution of the WOMAC index score in pa
Table 1
Sociodemographic characteristics of the participants
(N = 130)
Characteristic
Age, mean § SD, y 56 § 17
Female, n (%) 74 (57)
Marital status n (%)
Married 68 (52)
Widow 11 (8)
Divorced 24 (18)
Unmarried 26 (20)
In working life, n (%) 55 (42)
Smokers, n (%) 22 (17)
Diabetes, n (%) 11 (8)
Atherosclerosis, n (%) 1 (1)
BMI, mean § kg/m2 27 § 5
Operations, n (%)
1 85 (65)
2 17 (13)
3 11 (8)
4 4 (3)
5 2 (2)
7 2 (2)
11 1 (1)
Abbreviation: BMI = body mass index.
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did not follow a normal distribution, because most patients’ scores
concentrated around the lower points, indicating a higher level of
function and a lower level of stiffness. Cronbach’s a for the index
score was .98 and .95, .86, and .98 for the Pain, Stiffness, and Physi-
cal Function subscales, respectively (Table 2).
The Spearman correlation coefﬁcients between the subscales of the
WOMAC and the reference outcome measures (VAS-FA, LEFS, 15D, and
VAS general health) are presented in Table 3. The correlation between
the WOMAC Stiffness subscale and all reference outcome measures
was lower (r = 0.45−0.75) than the correlation between other subscales.
The correlations between the WOMAC and the VAS-FA (r =−0.84) and
the LEFS (r = ‒0.74) were high and moderate between the WOMAC and
the 15D (r =−0.58), respectively (Figs. 2−4). The correlation with VAS
general health ranged from low to moderate (r = 0.46−0.62; p < .001).
The Spearman correlation coefﬁcient between the WOMAC and the
VAS-FA Pain subscales was −0.78 (p < .001) (Fig. 5), and that between
the WOMAC Physical function and VAS-FA Function subscales was
−0.83 (p < .001) (Fig. 6), representing strong negative correlations. The
correlation between the WOMAC and time from surgery was −0.21
(p = .008) (Fig. 7).
The age-, BMI-, and sex-standardized relationships between WOMAC
and reference outcome measures (VAS-FA, LEFS, 15D, and VAS general
health) were assessed (Fig. 8). The relationships were strong with VAS-FA,tients having undergone ankle fracture surgery.
Fig. 2. Correlation between the WOMAC total score and the VAS-FA score.
*Spearman correlation coefﬁcient (95% CI).
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were statistically signiﬁcant (p < .001).Discussion
The WOMAC has been previously used to evaluate outcomes after
the treatment of foot and ankle osteoarthritis and has been used to vali-
date other PROMs for ankle osteoarthritis (36,37). When different
lower-extremity PROMs (including the WOMAC and the LEFS) were
used among patients with ankle osteoarthritis, none of the PROMs cap-
tured all patient concerns and a lack of consensus for which PROM to
use remains (37). Likewise, there is no consensus on which foot andTable 2
Instrument scores of the participants (N = 130)
Instrument Score
General health VAS, median (IQR) 16 (39)
Physical activity, FIT index, mean § SD 42 § 22
WOMAC, median (IQR)
Index score 8 (22)
Pain 6 (16)
Stiffness 8 (33)
Physical Function 6 (13)
VAS-FA, median (IQR)
Index score 83 (37)
Pain 81 (38)
Function 85 (37)
Other Complaints 82 (36)
LEFS score, median (IQR) 70 (18)
Abbreviations: LEFS = Lower Extremity Functional Scale; VAS-
FA = Visual Analogue Scale Foot and Ankle; WOMAC =Western
Ontario and McMaster Universities Osteoarthritis Index.ankle−speciﬁc PROMs to use among patients having undergone ankle
fracture surgery (1,6,38,39). Nevertheless, the WOMAC has been widely
used in the ﬁeld of foot and ankle surgery (40−43), although it has not
been previously validated for this purpose. The results of our study indi-
cate that the WOMAC provides valid and reliable scores among patients
after ankle fracture surgery.
The Likert scaled WOMAC for knee and hip osteoarthritis was ﬁrst
introduced by Bellamy et al (11,12). The Likert scaled WOMAC has
shown good validity and reliability in patients with hip, knee, and ankle
osteoarthritis (11,12,44). When the construct validity of the WOMAC
questionnaire was evaluated by using Rasch analysis (45), not all
items of the Likert-scale version ﬁt the Rasch model and the question-
naire was revised to fulﬁll the pertinent criteria for the Rasch model
(14,46−49). The VAS scaled WOMAC (version 3.0) was ﬁrst validated by
Kersten et al (17) to patch the poor ﬁt of some items in the Likert scaled
version. Each subscale of the VAS scaled WOMAC ﬁts well in the Rasch
model, and the Pain and Physical Function subscales show unidimen-
sional construct in factor analysis (17). The Stiffness subscale has shownTable 3
Spearman correlation coefﬁcients between the WOMAC, its subscales, and reference
measures
VAS FA LEFS 15D General Health
WOMAC ‒0.84* ‒0.74* ‒0.58* 0.55*
Pain subscale ‒0.77* ‒0.69* ‒0.68* 0.49*
Stiffness subscale ‒0.75* ‒0.66* ‒0.45* 0.46*
Physical Function subscale ‒0.83* ‒0.78* ‒0.62* 0.62*
Abbreviations: LEFS = Lower Extremity Functional Scale; VAS-FA = Visual Analogue Scale
Foot and Ankle; WOMAC =Western Ontario and McMaster Universities Osteoarthritis
Index.
*p < .001.
Fig. 3. Correlation between the WOMAC total score and the LEFS score.
*Spearman correlation coefﬁcient (95% CI).
Fig. 4. Correlation between the WOMAC total score and the 15D score.
*Spearman correlation coefﬁcient (95% CI).
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Fig. 5. Correlation between the WOMAC Pain subscale and the VAS-FA Pain subscale.
*Spearman correlation coefﬁcient (95% CI).
Fig. 6. Correlation between the WOMAC Physical Function subscale and the VAS-FA Function subscale.
*Spearman correlation coefﬁcient (95% CI).
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Fig. 7. Correlation between the WOMAC total score and time from surgery in years.
*Spearman correlation coefﬁcient (95% CI).
Fig. 8. Relationship between WOMAC and reference patient-reported outcome measures. Cohen’s standard for b values >.10, .30, and .50 represent small, moderate, and strong relation-
ships, respectively. Boxes represent the regression coefﬁcient b values of each reference PROM against theWOMAC score (reversed). Whiskers show 95% CIs. All relationships were statis-
tically signiﬁcant (p < .001). Abbreviations: LEFS = Lower Extremity Functional Scale; VAS FA = Visual Analogue Scale Foot and Ankle.
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This may be because the Stiffness subscale contains 2 items. The VAS
scaledWOMAC was used in our study.
In the present study, high Cronbach’s a values (>.90) indicate
excellent internal consistency for the WOMAC. The Cronbach’s a
was lowest in the Stiffness subscale (.86) yet still indicated very
good internal consistency. The results are consistent with the previ-
ous validation study of the WOMAC (17). The correlations and rela-
tionships with other validated foot and ankle‒speciﬁc PROMs were
high, indicating strong validity in patients with foot and ankle prob-
lems. Because the VAS General Health is a concise 1-item instru-
ment for assessing overall health, it is understandable that the
relationship with the VAS general health was not as high as the
foot-speciﬁc PROMs.
The strength of this study was the use of properly validated foot and
ankle−speciﬁc PROMs. The WOMAC (17) and the LEFS (24) have been
previously validated according to Rasch analysis (45), which offers manybeneﬁts compared with other validation methods (50). Because stiffness
is a known problem after ankle fractures (51−55), it is important to take
the stiffness into account when evaluating outcomes. However, our refer-
ence PROMs did not include such a subscale and thus may affect the
results of the correlations. Nevertheless, the VAS-FA and LEFS are valid
and reliable for foot and ankle surgery, and it is worthwhile to compare
the WOMAC with these outcome measures. The long duration (mean 4
years) between surgery and completing the questionnaires can be consid-
ered a weakness. Nonetheless, the analyses of the present study also pro-
vide important information on how the WOMAC questionnaire functions
years after surgery. The patients had high physical function and a low
level of pain according to the reference outcome measures. This may be
because they had had time to recover from the surgery. Despite the long
interval from surgery, ﬂoor or ceiling effects were not conﬁrmed, indicat-
ing that the WOMAC provided sufﬁcient targeting and coverage for the
present study population. Patients completed multiple questionnaires at
once, which may be a concern regarding the study reliability. This study
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points, whichmay also be considered a weakness.
In conclusion, this study provides support that the WOMAC yields
valid scores for assessing the outcomes of pain, stiffness, and physical
function after ankle fracture surgery. The results suggest that theWOMAC
provides sufﬁcient targeting and coverage even in long-term follow-up
after surgery. Future prospective studies with a more heterogeneous pop-
ulation of patients having undergone foot and ankle surgery may provide
further insight for themeasurement properties of theWOMAC.References
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